Carmine N. Stengone

Companies

• Contineum Therapeutics, Inc.Board member Apr 4, 2024 to now¹
• Contineum Therapeutics, Inc.Chief executive officer Apr 4, 2024 to now¹
• Contineum Therapeutics, Inc.President Apr 4, 2024 to now¹
• KIORA PHARMACEUTICALS INCBoard member Aug 10, 2023 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• CTContineum Therapeutics, Inc. CTNM17,217 shares³$118.7K at $6.89Sep 8, 2026
• KPKIORA PHARMACEUTICALS INC KPRX1,250 shares⁴$3.0K at $2.36Sep 11, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 8, 2026Sold 2,500 shares at $16.46 of Contineum Therapeutics, Inc.³
• Sep 8, 2026Exercised options 2,500 shares at $1.01 of Contineum Therapeutics, Inc.³
• Aug 3, 2026Sold 2,500 shares at $16.01 of Contineum Therapeutics, Inc.⁵
• Aug 3, 2026Exercised options 2,500 shares at $1.01 of Contineum Therapeutics, Inc.⁵
• Jul 8, 2026Sold 2,500 shares at $16.00 of Contineum Therapeutics, Inc.⁶
• Jul 8, 2026Exercised options 2,500 shares at $1.01 of Contineum Therapeutics, Inc.⁶
• Jun 30, 2026Sold 10,000 shares at $16.01 of Contineum Therapeutics, Inc.⁷
• Jun 30, 2026Exercised options 2,500 shares at $1.26 of Contineum Therapeutics, Inc.⁷
• Jun 30, 2026Exercised options 7,500 shares at $1.01 of Contineum Therapeutics, Inc.⁷
• Feb 25, 2026Sold 2,700 shares at $16.02 of Contineum Therapeutics, Inc.⁸
• Feb 25, 2026Exercised options 2,700 shares at $1.26 of Contineum Therapeutics, Inc.⁸
• Feb 24, 2026Sold 4,400 shares at $16.02 of Contineum Therapeutics, Inc.⁸
• Feb 24, 2026Exercised options 4,400 shares at $1.26 of Contineum Therapeutics, Inc.⁸
• Feb 11, 2026Sold 400 shares at $16.00 of Contineum Therapeutics, Inc.⁹
• Feb 11, 2026Exercised options 400 shares at $1.26 of Contineum Therapeutics, Inc.⁹
• Sep 11, 2024Bought 1,250 shares at $3.68 of KIORA PHARMACEUTICALS INC⁴